5 Key Analyst Inquiries You Should Know From Ingersoll Rand’s Q4 Earnings Discussion

Ingersoll Rand Surpasses Expectations in Q4

Ingersoll Rand delivered a strong fourth quarter, outperforming analyst forecasts for both revenue and adjusted earnings per share. The company credited its success to the ongoing growth of recurring revenue, effective execution of its mergers and acquisitions plan, and steady order increases across major divisions. CEO Vicente Reynal noted that recurring revenue exceeded $450 million in 2025, supported by a solid $1.1 billion order backlog. Recent acquisitions have also enhanced the company's scale and technological strengths. Reynal remarked, “Our teams remain agile with the help of IRX and continue to harness our growth engine to excel in our markets.”

Should You Consider Investing in IR?

Curious if now is the right time to invest in Ingersoll Rand?

Key Takeaways from Ingersoll Rand’s Q4 2025 Results

• Total Revenue: $2.09 billion, beating analyst projections of $2.04 billion (10.1% year-over-year growth, 2.6% above expectations)
• Adjusted Earnings Per Share: $0.96, surpassing the $0.90 estimate (6.6% above forecast)
• Adjusted EBITDA: $580.1 million, exceeding the $560.3 million estimate (27.7% margin, 3.5% beat)
• 2026 Adjusted EPS Guidance: $3.51 at the midpoint, 1.3% below analyst expectations
• 2026 EBITDA Guidance: $2.16 billion at the midpoint, slightly under the $2.19 billion estimate
• Operating Margin: 18.7%, down from 20% in the prior year’s quarter
• Market Value: $38.07 billion

While management’s prepared remarks are informative, the unscripted analyst Q&A often reveals deeper insights and challenges. Here are the questions that stood out to us this quarter:

Top 5 Analyst Questions from the Q4 Earnings Call

• Michael Patrick Halloran (Baird): Asked about assumptions behind guidance and trends in short-cycle markets. CEO Reynal explained that forecasts are based on stable market conditions, with recurring revenue holding steady and life sciences demand improving.
• Julian C.H. Mitchell (Barclays): Inquired about the seasonality of organic growth and margin trends. CFO Vikram U. Kini indicated that the first quarter is expected to be flat or slightly lower, with growth picking up in later quarters and margin improvement anticipated in the second half as tariff effects lessen.
• Joseph John O'Dea (Wells Fargo): Sought details on the acquisition pipeline and recurring revenue expansion. Reynal described a healthy pipeline focused on smaller, bolt-on deals, with recurring revenue boosted by new contracts and technology advancements.
• Nigel Edward Coe (Wolfe Research): Asked about margin expectations by segment and investment spending. Kini noted that ITS margins would remain steady due to tariffs and growth investments, while PST margins should improve thanks to easier comparisons and better operational execution.
• Nicole Sheree DeBlase (Deutsche Bank): Queried about organic growth by segment. Kini responded that both PST and ITS are projected to see modest growth, with PST slightly ahead due to momentum in life sciences.

Upcoming Catalysts to Watch

Looking ahead, analysts will monitor several key factors: the pace at which recurring revenue and backlog are converted into reported sales, the integration and performance of recent acquisitions (notably Synomics), and continued order strength in life sciences and aftermarket businesses. Margin recovery as tariff pressures ease and the impact of productivity initiatives will also be important indicators of future performance.

Ingersoll Rand shares recently climbed to $97.17, up from $94.21 before the earnings release. Wondering if there’s value in the stock?

Our Top Stock Picks Right Now

Relying on just a handful of stocks can leave your portfolio vulnerable. Now is the time to secure high-quality investments before the market broadens and prices move higher.

Don’t wait for the next bout of market turbulence. Explore our Top 6 Stocks to Buy This Week—a carefully selected group of high-quality companies that have delivered a 244% return over the past five years (as of June 30, 2025).

This list features well-known names like Nvidia, which soared 1,326% from June 2020 to June 2025, as well as lesser-known success stories such as Kadant, which achieved a 351% five-year return. Discover your next standout investment with StockStory today.